BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36973963)

  • 21. Optimal Volume Assessment for Serous Fluid Cytology.
    Christofidis K; Theochari M; Mavropoulos Papoudas S; Kiohou L; Sousouris S; Dimitriadou A; Volakakis N; Maounis N; Mikou P
    Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment.
    Pergaris A; Stefanou D; Keramari P; Sousouris S; Kavantzas N; Gogas H; Mikou P
    Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Stratification of Pleural Fluid Cytology Based on the International System for Reporting Serous Fluid Cytology in a Tertiary Care Centre.
    Bharti S; Nalwa A; Elhence PA; Rao M; Bharti JN; Khera S; Vedant D; Vishwajeet V; Goel A
    Acta Cytol; 2022; 66(5):449-456. PubMed ID: 35413720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of cytology in distinguishing malignant mesothelioma: An institutional experience of 210 cases reclassified according to the International System for Reporting Serous Fluid Cytopathology (ISRSFC).
    Straccia P; Magnini D; Trisolini R; Lococo F; Chiappetta M; Cancellieri A
    Cytopathology; 2022 Jan; 33(1):77-83. PubMed ID: 34046958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of a tiered cytology diagnostic reporting system in assessing the risk of malignancy in indeterminate serous effusions.
    Hou T; Landon G; Stewart J; Roy-Chowdhuri S
    Cancer Cytopathol; 2021 Jan; 129(1):75-82. PubMed ID: 32809259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The International System for Reporting Serous Fluid Cytopathology: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies.
    Jamal FE; Vey JA; Proctor T; Ishak A; Schmitt FC; Nikas IP
    Adv Anat Pathol; 2024 Jul; 31(4):256-264. PubMed ID: 38695284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Root cause analysis of indeterminate diagnoses in serous fluids cytopathology.
    Gokozan HN; Harbhajanka A; Lyden S; Michael CW
    Diagn Cytopathol; 2021 May; 49(5):633-639. PubMed ID: 33125186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Ancillary Techniques in Reporting Serous Fluid Cytology - "Redefining Categories, Refining Diagnosis".
    Kapoor S; Samanta S; Kaur K
    J Cytol; 2024; 41(2):96-104. PubMed ID: 38779601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of the international system for reporting serous fluid cytopathology on reporting various body fluids; experience of a tertiary care hospital.
    Kolte S; Zaheer S; Aden D; Ranga S
    Cytojournal; 2022; 19():52. PubMed ID: 36128470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective analysis of pleural effusion specimens based on the newly proposed International System for Reporting Serous Fluid Cytopathology.
    Xu Y; Hu AY; Wang SM; Wang Q; Pan YC; Zhang SH
    Diagn Cytopathol; 2021 Sep; 49(9):997-1007. PubMed ID: 34019334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the Milan System for Reporting Salivary Gland Cytopathology: A 5-year institutional experience.
    Viswanathan K; Sung S; Scognamiglio T; Yang GCH; Siddiqui MT; Rao RA
    Cancer Cytopathol; 2018 Aug; 126(8):541-551. PubMed ID: 29797690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of the Milan System for Reporting Submandibular Gland Cytopathology: An international, multi-institutional study.
    Maleki Z; Baloch Z; Lu R; Shafique K; Song SJ; Viswanathan K; Rao RA; Lefler H; Fatima A; Wiles A; Jo VY; Wang H; Fadda G; Powers CN; Ali SZ; Pantanowitz L; Siddiqui MT; Nayar R; Klijanienko J; Barkan GA; Krane JF; Rossi ED; Callegari F; Kholová I; Bongiovanni M; Faquin WC; Pusztaszeri MP
    Cancer Cytopathol; 2019 May; 127(5):306-315. PubMed ID: 31050186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinico-cytopathologic analysis of 574 Pericardial Effusion Specimens: Application of the international system for reporting serous fluid cytopathology (ISRSFC) and long-term clinical follow-up.
    Song MJ; Jo U; Jeong JS; Cho KJ; Gong G; Cho YM; Song JS
    Cancer Med; 2021 Dec; 10(24):8899-8908. PubMed ID: 34747147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are we ready to develop a tiered scheme for the effusion cytology? A comprehensive review and analysis of the literature.
    Farahani SJ; Baloch Z
    Diagn Cytopathol; 2019 Nov; 47(11):1145-1159. PubMed ID: 31301215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of International System for Reporting Serous Fluid Cytopathology: A systematic review and meta-analysis in malignancy diagnosis.
    Ahuja S; Ahuja R; Pandey S; Zaheer S
    Cancer Cytopathol; 2024 Apr; ():. PubMed ID: 38613789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective application of the Milan System for reporting salivary gland cytopathology: A Cancer Center experience.
    Leite AA; Vargas PA; Dos Santos Silva AR; Galvis MM; de Sá RS; Lopes Pinto CA; Kowalski LP; Saieg M
    Diagn Cytopathol; 2020 Sep; 48(9):821-826. PubMed ID: 32374949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serous fluid cytopathology: International system].
    Basset C; Collin L; Vielh P; Courtade-Saïdi M;
    Ann Pathol; 2023 Mar; 43(2):96-113. PubMed ID: 36907792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Milan System for Reporting Salivary Gland Cytopathology: Assessment of Cytohistological Concordance and Risk of Malignancy.
    Jha S; Mitra S; Purkait S; Adhya AK
    Acta Cytol; 2021; 65(1):27-39. PubMed ID: 33045705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of the Milan System for Reporting Salivary Gland Cytology, with focus on the incidence and histologic correlates of atypia of undetermined significance (AUS) and salivary gland neoplasm of uncertain malignant potential (SUMP): A 3-year institutional experience.
    Cormier CM; Agarwal S
    Cancer Cytopathol; 2022 Apr; 130(4):303-312. PubMed ID: 34875145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Stratification of Breast Fine-Needle Aspiration Biopsy Specimens Performed without Radiologic Guidance by Application of the International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Cytopathology.
    Sarangi S; Rao M; Elhence PA; Nalwa A; Bharti JN; Khera S; Vedant D; Vishwajeet V; Vishnoi JR; Sharma N; Pareek P
    Acta Cytol; 2021; 65(6):483-493. PubMed ID: 34535580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.